www.reuters.com Open in urlscan Pro
2600:9000:2009:5200:15:5a3e:9d40:93a1  Public Scan

URL: https://www.reuters.com/business/healthcare-pharmaceuticals/covid-remains-public-health-emergency-says-who-2023-01-30/
Submission: On December 04 via api from US — Scanned from US

Form analysis 0 forms found in the DOM

Text Content

Skip to main content

Exclusive news, data and analytics for financial market professionalsLearn more
aboutRefinitiv

 * World
   Browse World
    * Africa
    * Americas
    * Asia Pacific
    * China
    * Europe
    * India
    * Israel and Hamas at War
   
    * Japan
    * Middle East
    * Ukraine and Russia at War
    * United Kingdom
    * United States
    * Reuters NEXT

 * US Election
 * Business
   Browse Business
    * Aerospace & Defense
    * Autos & Transportation
    * Davos
    * Energy
    * Environment
    * Finance
    * Healthcare & Pharmaceuticals
   
    * Media & Telecom
    * Retail & Consumer
    * Future of Health
    * Future of Money
    * Take Five
    * World at Work

 * Markets
   Browse Markets
    * Asian Markets
    * Carbon Markets
    * Commodities
    * Currencies
    * Deals
    * Emerging Markets
    * ETFs
    * European Markets
   
    * Funds
    * Global Market Data
    * Rates & Bonds
    * Stocks
    * U.S. Markets
    * Wealth
    * Macro Matters

 * Sustainability
   Browse Sustainability
    * Boards, Policy & Regulation
    * Climate & Energy
    * Land Use & Biodiversity
    * Society & Equity
   
    * Sustainable Finance & Reporting
    * The Switch
    * Reuters Impact
    * COP29

 * Legal
   Browse Legal
    * Government
    * Legal Industry
    * Litigation
    * Transactional
    * US Supreme Court

 * Breakingviews
   Browse Breakingviews
    * Breakingviews Predictions

 * Technology
   Browse Technology
    * Artificial Intelligence
    * Cybersecurity
    * Space
    * Disrupted

 * More
   Investigations
   Sports
    * Athletics
    * Baseball
    * Basketball
    * Cricket
    * Cycling
    * Formula 1
    * Golf
    * NFL
    * NHL
    * Soccer
    * Tennis
   
   Science
   Lifestyle
   Graphics
   Pictures
   Wider Image
   Podcasts
   Fact Check
   Video
   Sponsored Content
    * Reuters Plus
    * Press Releases
   
   Live

My News

Sign InSubscribe



WHO MAINTAINS HIGHEST ALERT OVER COVID, BUT SEES HOPE AHEAD

By Reuters
January 30, 20236:45 AM HSTUpdated 2 years ago
Text
 * Small Text
 * Medium Text
 * Large Text

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

A nurse prepares a shot for Jonathan Halter as the German embassy begins its
roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing
United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas
Peter/File Photo Purchase Licensing Rights, opens new tab
Jan 30 (Reuters) - The World Health Organization (WHO) said on Monday that
COVID-19 continues to constitute a public health emergency of international
concern, its highest form of alert.
The pandemic was likely in a "transition point" that continues to need careful
management to "mitigate the potential negative consequences", the agency added
in a statement.
It is three years since the WHO first declared that COVID represented a global
health emergency. More than 6.8 million people have died during the outbreak,
which has touched every country on Earth, ravaging communities and economies.
Advertisement · Scroll to continue
Report this ad
However, the advent of vaccines and treatments has changed the pandemic
situation considerably since 2020, and WHO Director-General Tedros Adhanom
Ghebreyesus has said he hopes to see an end to the emergency this year,
particularly if access to the counter-measures can be improved globally.
"We remain hopeful that in the coming year, the world will transition to a new
phase in which we reduce (COVID) hospitalisations and deaths to their lowest
possible level,” Tedros told a separate WHO meeting on Monday.
Advertisement · Scroll to continue

Advisers to the WHO expert committee on the pandemic's status told Reuters in
December that it was likely not the moment to end the emergency given the
uncertainty over the wave of infections in China after it lifted its strict
zero-COVID measures at the end of 2022.


Keep up with the latest medical breakthroughs and healthcare trends with the
Reuters Health Rounds newsletter. Sign up here.

Reporting by Abinaya Vijayaraghavan in Bengaluru and Jennifer Rigby in London;
Editing by Toby Chopra and Nick Macfie

Our Standards: The Thomson Reuters Trust Principles., opens new tab

 * Suggested Topics:
 * Healthcare & Pharmaceuticals
 * COVID-19
 * Regulatory Oversight
 * Government Health Policy
 * Lawsuits

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

Purchase Licensing Rights


READ NEXT

 * Healthcare & PharmaceuticalscategoryExclusive: Big hedge funds call on
   doctors, scientists for an edge on pharma
 * Healthcare & PharmaceuticalscategoryNovavax to sell Czech manufacturing unit
   to Novo Nordisk for $200 mln
 * California suspends Raw Farm's raw milk products after bird flu detection
 * Retail & ConsumercategoryE. coli outbreak tied to McDonald's Quarter Pounders
   has ended, CDC says
 * Healthcare & PharmaceuticalscategoryHumana CFO Susan Diamond to step down in
   latest management change
 * Healthcare & PharmaceuticalscategoryUnitedHealth forecasts 2025 profit
   largely in line with estimates




BUSINESS


 * EURO ZONE BUSINESS ACTIVITY DECLINES SHARPLY IN NOVEMBER, PMI SHOWS
   
   category · December 3, 2024 · 11:05 PM HST · 13 min ago
   
   Business activity across the euro zone fell sharply last month as the bloc's
   dominant services sector joined the manufacturing sector in contracting,
   according to a survey which showed a broadbased decline.

 * BusinesscategoryGerman firms' China market sentiment falls to record low,
   survey shows11:04 PM HST · Updated 14 min ago
 * MarketscategoryOECD warns of protectionism risk to global growth outlook11:03
   PM HST · Updated 15 min ago
 * Autos & TransportationcategoryStellantis denies report about picking Apple's
   Maestri as new CEO11:03 PM HST · Updated 15 min ago
 * Healthcare & PharmaceuticalscategoryNovavax to sell Czech manufacturing unit
   to Novo Nordisk for $200 mln11:00 PM HST · Updated 18 min ago




SITE INDEX


LATEST

 * Home
 * Authors
 * Topic Sitemap
 * Archive
 * Article Sitemap


BROWSE

 * World
 * Business
 * Markets
 * Sustainability
 * Legal
 * Breakingviews
 * Technology
 * Investigations
 * Sports
 * Science
 * Lifestyle


MEDIA

 * 
   Videos
 * 
   Pictures
 * 
   Graphics
 * 
   Podcasts


ABOUT REUTERS

 * About Reuters, opens new tab
 * Advertise with Us, opens new tab
 * Careers, opens new tab
 * Reuters News Agency, opens new tab
 * Brand Attribution Guidelines, opens new tab
 * Reuters and AI, opens new tab
 * Reuters Leadership, opens new tab
 * Reuters Fact Check
 * Reuters Diversity Report, opens new tab


STAY INFORMED

 * Download the App (iOS), opens new tab
 * Download the App (Android), opens new tab
 * Newsletters


INFORMATION YOU CAN TRUST

Reuters, the news and media division of Thomson Reuters, is the world’s largest
multimedia news provider, reaching billions of people worldwide every day.
Reuters provides business, financial, national and international news to
professionals via desktop terminals, the world's media organizations, industry
events and directly to consumers.


FOLLOW US

 * X
 * Facebook
 * Instagram
 * Youtube
 * Linkedin


THOMSON REUTERS PRODUCTS

 * WESTLAW, OPENS NEW TAB
   
   BUILD THE STRONGEST ARGUMENT RELYING ON AUTHORITATIVE CONTENT,
   ATTORNEY-EDITOR EXPERTISE, AND INDUSTRY DEFINING TECHNOLOGY.

 * ONESOURCE, OPENS NEW TAB
   
   THE MOST COMPREHENSIVE SOLUTION TO MANAGE ALL YOUR COMPLEX AND EVER-EXPANDING
   TAX AND COMPLIANCE NEEDS.

 * CHECKPOINT, OPENS NEW TAB
   
   THE INDUSTRY LEADER FOR ONLINE INFORMATION FOR TAX, ACCOUNTING AND FINANCE
   PROFESSIONALS.


LSEG PRODUCTS

 * WORKSPACE, OPENS NEW TAB
   
   ACCESS UNMATCHED FINANCIAL DATA, NEWS AND CONTENT IN A HIGHLY-CUSTOMISED
   WORKFLOW EXPERIENCE ON DESKTOP, WEB AND MOBILE.

 * DATA CATALOGUE, OPENS NEW TAB
   
   BROWSE AN UNRIVALLED PORTFOLIO OF REAL-TIME AND HISTORICAL MARKET DATA AND
   INSIGHTS FROM WORLDWIDE SOURCES AND EXPERTS.

 * WORLD-CHECK, OPENS NEW TAB
   
   SCREEN FOR HEIGHTENED RISK INDIVIDUAL AND ENTITIES GLOBALLY TO HELP UNCOVER
   HIDDEN RISKS IN BUSINESS RELATIONSHIPS AND HUMAN NETWORKS.

 * Advertise With Us, opens new tab
 * Advertising Guidelines
 * Purchase Licensing Rights, opens new tab

 * Cookies, opens new tab
 * Terms of Use
 * Privacy, opens new tab
 * Digital Accessibility, opens new tab
 * Corrections
 * Site Feedback, opens new tab

All quotes delayed a minimum of 15 minutes. See here for a complete list of
exchanges and delays.

© 2024 Reuters. All rights reserved